Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Market Cap	12.86B -7.1%
Revenue (ttm)	6.16B +1.6%
Net Income	536.00M -25.3%
EPS	10.67 -25.4%
Shares Out	50.25M
PE Ratio	24.00
Forward PE	17.44
Dividend	3.50 (1.35%)
Ex-Dividend Date	Dec 29, 2025

Volume	80,300
Open	260.00
Previous Close	259.00
Day's Range	255.00 - 260.00
52-Week Range	239.00 - 444.00
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2026

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incor...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1946
• Employees: 220
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4574

Financial Performance

In 2025, Taiko Pharmaceutical's revenue was 6.40 billion, an increase of 1.67% compared to the previous year's 6.29 billion. Earnings were 923.00 million, an increase of 2.78%.